By Professor Michael Proinsias Farrell

Journal articles

Campbell G; Hall WD; Peacock A; Lintzeris N; Bruno R; Larance B; Nielsen S; Cohen M; Chan G; Mattick RP; Blyth F; Shanahan M; Dobbins T; Farrell M; Degenhardt L, 2018, 'Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study', The Lancet Public Health, 3, pp. e341 - e350, http://dx.doi.org/10.1016/S2468-2667(18)30110-5

Stockings E; Zagic D; Campbell G; Weier M; Hall WD; Nielsen S; Herkes GK; Farrell M; Degenhardt L, 2018, 'Evidence for cannabis and cannabinoids for epilepsy: A systematic review of controlled and observational evidence', Journal of Neurology, Neurosurgery and Psychiatry, 89, pp. 741 - 753, http://dx.doi.org/10.1136/jnnp-2017-317168

Hall WD; Farrell M, 2018, 'Reducing the opioid overdose death toll in North America', PLoS Medicine, 15, http://dx.doi.org/10.1371/journal.pmed.1002626

Stockings E; Shakeshaft A; Farrell M, 2018, 'Community Approaches for Reducing Alcohol-Related Harms: an Overview of Intervention Strategies, Efficacy, and Considerations for Future Research', Current Addiction Reports, 5, pp. 274 - 286, http://dx.doi.org/10.1007/s40429-018-0210-2

Lappin JM; Darke S; Farrell M, 2018, 'Methamphetamine use and future risk for Parkinson's disease: Evidence and clinical implications', Drug and Alcohol Dependence, 187, pp. 134 - 140, http://dx.doi.org/10.1016/j.drugalcdep.2018.02.032

O Reilly DE; Dooley L; Watson GA; Farrell MP; Clarke RM; Nolan A; Nolan C; Berkeley E; O'Donovan E; Gallagher DJ, 2018, 'BRCA1/BRCA2 predictive genetic testing in an Irish population: A missed opportunity.', Journal of Clinical Oncology, 36, pp. e13530 - e13530, http://dx.doi.org/10.1200/jco.2018.36.15_suppl.e13530

Hall W; Farrell M, 2018, 'Prisoners and risk of injury after release', The Lancet Public Health, 3, pp. e209 - e210, http://dx.doi.org/10.1016/S2468-2667(18)30073-2

Nielsen S; Larney S; Farrell M, 2018, 'Commentary on McDonald et al. (2018): Intranasal naloxone—from the laboratory to the real world', Addiction, 113, pp. 494 - 495, http://dx.doi.org/10.1111/add.14087

Peacock A; Larance B; Farrell M; Cairns R; Buckley N; Degenhardt L, 2018, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A postmarketing study protocol', BMJ Open, 8, http://dx.doi.org/10.1136/bmjopen-2017-020006

Rice N; Vu M; Kong C; Mauldin M; Tambazidis A; Hoppe M; Fitzsimmons P; Farrell M; Clark D; Dewald E; Smalyuk V, 2018, 'Capsule Shimming Developments for National Ignition Facility (NIF) Hohlraum Asymmetry Experiments', Fusion Science and Technology, 73, pp. 279 - 284, http://dx.doi.org/10.1080/15361055.2017.1389603

Huang H; Engelhorn K; Sequoia K; Greenwood A; Sweet W; Carlson L; Elsner F; Farrell M, 2018, 'Metrology Feasibility Study in Support of the National Direct-Drive Program', Fusion Science and Technology, 73, pp. 98 - 106, http://dx.doi.org/10.1080/15361055.2017.1387460

Regan SP; Goncharov VN; Sangster TC; Campbell EM; Betti R; Anderson KS; Bernat T; Bose A; Boehly TR; Bonino MJ; Cao D; Chapman R; Collins TJB; Craxton RS; Davis AK; Delettrez JA; Edgell DH; Epstein R; Farrell M; Forrest CJ; Frenje JA; Froula DH; Johnson MG; Gibson C; Glebov VY; Greenwood A; Harding DR; Hohenberger M; Hu SX; Huang H; Hund J; Igumenshchev IV; Jacobs-Perkins DW; Janezic RT; Karasik M; Keck RL; Kelly JH; Kessler TJ; Knauer JP; Kosc TZ; Loucks SJ; Marozas JA; Marshall FJ; McCrory RL; McKenty PW; Meyerhofer DD; Michel DT; Myatt JF; Obenschain SP; Petrasso RD; Petta N; Radha PB; Rosenberg MJ; Schmitt AJ; Schmitt MJ; Schoff M; Seka W; Shmayda WT; Shoup MJ; Shvydky A; Solodov AA; Stoeckl C; Sweet W; Taylor C; Taylor R; Theobald W; Ulreich J; Wittman MD; Woo KM; Zuegel JD, 2018, 'The National Direct-Drive Program: OMEGA to the National Ignition Facility', Fusion Science and Technology, 73, pp. 89 - 97, http://dx.doi.org/10.1080/15361055.2017.1397487

Larance B; Dobbins T; Peacock A; Ali R; Bruno R; Lintzeris N; Farrell M; Degenhardt L, 2018, 'The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study', The Lancet Psychiatry, 5, pp. 155 - 166, http://dx.doi.org/10.1016/S2215-0366(18)30003-8

Nielsen S; Germanos R; Weier M; Pollard J; Degenhardt L; Hall W; Buckley N; Farrell M, 2018, 'The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews', Current Neurology and Neuroscience Reports, 18, http://dx.doi.org/10.1007/s11910-018-0814-x

Stockings E; Campbell G; Hall WD; Nielsen S; Zagic D; Rahman R; Murnion B; Farrell M; Weier M; Degenhardt L, 2018, 'Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: A systematic review and meta-analysis of controlled and observational studies', Pain, 159, pp. 1932 - 1954, http://dx.doi.org/10.1097/j.pain.0000000000001293

Lappin JM; Darke S; Duflou J; Kaye S; Farrell M, 2018, 'Fatal stroke in pregnancy and the puerperium: Case series', Stroke, 49, pp. 3050 - 3053, http://dx.doi.org/10.1161/STROKEAHA.118.023274

Xu H; Huang H; Walker J; Schoff M; Elsner F; Farrell M, 2018, 'Gradient coating for NIF double shell targets', Surface and Coatings Technology, 349, pp. 838 - 845, http://dx.doi.org/10.1016/j.surfcoat.2018.05.080

Stebner AP; Wehrenberg CE; Li B; Randall GC; John KK; Hudish GA; Maddox BR; Farrell M; Park H-S; Remington BA; Ortiz M; Ravichandran G, 2018, 'Strength of tantalum shocked at ultrahigh pressures', Materials Science and Engineering: A, 732, pp. 220 - 227, http://dx.doi.org/10.1016/j.msea.2018.06.105

Larney S; Farrell M, 2017, 'Prisoner suicide: a multilevel problem', The Lancet Psychiatry, 4, pp. 894 - 895, http://dx.doi.org/10.1016/S2215-0366(17)30435-2

Quinn B; Seed C; Keller A; Maher L; Wilson D; Farrell M; Caris S; Williams J; Madden A; Thompson A; Pink J; Hellard ME, 2017, 'Re-examining blood donor deferral criteria relating to injecting drug use', International Journal of Drug Policy, 48, pp. 9 - 17, http://dx.doi.org/10.1016/j.drugpo.2017.05.058

Martire KA; clare P; courtney R; bonevski B; boland V; borland R; Doran C; Farrell M; hall W; Iredale J; siahpush M; mattick R, 2017, 'Smoking and Finances: Baseline Characteristics of Low Income Daily Smokers in the FISCALS Cohort', International Journal for Equity in Health, 16, pp. 157, http://dx.doi.org/10.1186/s12939-017-0643-6

Lappin JM; Darke S; Farrell M, 2017, 'Stroke and methamphetamine use in young adults: a review', Journal of Neurology Neuropsychiatry and Psychiatry, 88, pp. 1079 - 1091, http://dx.doi.org/10.1136/jnnp-2017-316071

Bonevski B; Borland R; Paul CL; Richmond RL; Farrell M; Baker A; Gartner CE; Lawn S; Thomas DP; Walker N, 2017, 'No smoker left behind: It’s time to tackle tobacco in Australian priority populations', Medical Journal of Australia, 207, pp. 141 - 142, http://dx.doi.org/10.5694/mja16.01425

Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalfe C; Shaw J; Hickman M, 2017, 'Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England', Addiction, 112, pp. 1408 - 1418, http://dx.doi.org/10.1111/add.13779

Nielsen S; Sabioni P; Trigo JM; Ware MA; Betz-Stablein BD; Murnion B; Lintzeris N; Khor KE; Farrell M; Smith A; Le Foll B, 2017, 'Opioid-sparing effect of cannabinoids: A systematic review and meta-analysis', Neuropsychopharmacology, 42, pp. 1752 - 1765, http://dx.doi.org/10.1038/npp.2017.51

Stockings E; Farrell M, 2017, 'Drinking-reduction goals offer potential to widen the options for measuring and treating alcohol dependence', The Lancet Psychiatry, 4, pp. 430 - 431, http://dx.doi.org/10.1016/S2215-0366(17)30187-6

Saunders JB; Degenhardt L; Farrell M, 2017, 'Excessive gambling and gaming: addictive disorders?', The Lancet Psychiatry, 4, pp. 433 - 435, http://dx.doi.org/10.1016/S2215-0366(17)30210-9

Lappin JM; Sara GE; Farrell M, 2017, 'Methamphetamine-related psychosis: an opportunity for assertive intervention and prevention', Addiction, 112, pp. 927 - 928, http://dx.doi.org/10.1111/add.13663

Conroy M; Gallagher DJ; Farrell MP, 2017, 'Prevalence of BRCA1/2 mutations among an Irish cohort unrestricted by testing eligibility thresholds', JOURNAL OF CLINICAL ONCOLOGY, 35, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.e13013

Degenhardt L; Sara G; McKetin R; Roxburgh A; Dobbins T; Farrell M; Burns L; Hall WD, 2017, 'Crystalline methamphetamine use and methamphetamine-related harms in Australia', Drug and Alcohol Review, 36, pp. 160 - 170, http://dx.doi.org/10.1111/dar.12426

Stillwell G; Jones H; Shaw J; Farrell M; Marsden J, 2017, 'An evaluation of opioid substitution treatment in prison on risk of mortality in period immediately after prison: Does leaving prison on OST reduce the risk of death?', DRUG AND ALCOHOL DEPENDENCE, 171, pp. E197 - E197, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.538

Campbell G; Bruno R; Cohen M; Hall W; Nielsen S; Lintzeris N; Larance B; Mattick RP; Farrell M; Degenhardt L, 2017, 'Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic non-cancer pain: Different measures, same patients?', DRUG AND ALCOHOL DEPENDENCE, 171, pp. E33 - E33, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.103

Ritter A; Hoang VP; Cao VL; Shanahan M; Shukla N; Perez P; Farrell M, 2017, 'Modelling heroin careers over 40 years: Social costs', DRUG AND ALCOHOL DEPENDENCE, 171, pp. E177 - E177, http://dx.doi.org/10.1016/j.drugalcdep.2016.08.486

Farrell MP; Hearty KP; Gallagher DJ, 2017, 'Prevalence of pathogenic mismatch repair mutations in an Irish cohort after clinical and molecular pre-selection.', JOURNAL OF CLINICAL ONCOLOGY, 35, http://dx.doi.org/10.1200/JCO.2017.35.4_suppl.574

Darke S; Larney S; Farrell M, 2017, 'Yes, people can die from opiate withdrawal', Addiction, 112, pp. 199 - 200, http://dx.doi.org/10.1111/add.13512

Saunders JB; Hao W; Long J; King DL; Mann K; Fauth-Bühler M; Rumpf HJ; Bowden-Jones H; Rahimi-Movaghar A; Chung T; Chan E; Bahar N; Achab S; Lee HK; Potenza M; Petry N; Spritzer D; Ambekar A; Derevensky J; Griffiths MD; Pontes HM; Kuss D; Higuchi S; Mihara S; Assangangkornchai S; Sharma M; El Kashef A; Ip P; Farrell M; Scafato E; Carragher N; Poznyak V, 2017, 'Gaming disorder: Its delineation as an important condition for diagnosis, management, and prevention', Journal of Behavioral Addictions, 6, pp. 271 - 279, http://dx.doi.org/10.1556/2006.6.2017.039

Courtney RJ; Clare P; Boland V; Martire KA; Bonevski B; Hall W; Siahpush M; Borland R; Doran CM; West R; Farrell M; Mattick RP, 2017, 'Predictors of retention in a randomised trial of smoking cessation in low-socioeconomic status Australian smokers', Addictive Behaviors, 64, pp. 13 - 20, http://dx.doi.org/10.1016/j.addbeh.2016.07.019

Van Buskirk J; Griffiths P; Farrell M; Degenhardt L, 2017, 'Trends in new psychoactive substances from surface and “dark” net monitoring', The Lancet Psychiatry, 4, pp. 16 - 18, http://dx.doi.org/10.1016/S2215-0366(16)30405-9

Nielsen S; Menon N; Larney S; Farrell M; Degenhardt L, 2016, 'Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal', Addiction, 111, pp. 2177 - 2186, http://dx.doi.org/10.1111/add.13517

Lappin JM; Roxburgh A; Kaye S; Chalmers J; Sara G; Dobbins T; Burns L; Farrell M, 2016, 'Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population', International Journal of Drug Policy, 38, pp. 16 - 20, http://dx.doi.org/10.1016/j.drugpo.2016.10.018

Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalf C; Shaw J; Hickman M, 2016, 'Does exposure to opioid substitution treatment at prison release reduce the risk of death? A prospective, observational study in England', LANCET, 388, pp. 11 - 11, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398515600012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Casey J; Flood K; Ennis S; Doyle E; Farrell M; Lynch SA, 2016, 'Intra-familial variability associated with recessive RYR1 mutation diagnosed prenatally by exome sequencing', PRENATAL DIAGNOSIS, 36, pp. 1020 - 1026, http://dx.doi.org/10.1002/pd.4925

Darke S; Farrell M, 2016, 'Commentary on Singh et al. (2016): Still searching for the answer', Addiction (Abingdon, England), 111, pp. 1347, http://dx.doi.org/10.1111/add.13369

Gethin A; Trimingham T; Chang T; Farrell M; Ross J, 2016, 'Coping with problematic drug use in the family: An evaluation of the Stepping Stones program', Drug and alcohol review, 35, pp. 470 - 476, http://dx.doi.org/10.1111/dar.12327

Campbell G; Bruno R; Lintzeris N; Cohen M; Nielsen S; Hall W; Larance B; Mattick RP; Blyth F; Farrell M; Degenhardt L, 2016, 'Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: Do different measures identify the same patients?', Pain, 157, pp. 1489 - 1498, http://dx.doi.org/10.1097/j.pain.0000000000000548

Bonevski B; Guillaumier A; Shakeshaft A; Farrell M; Tzelepis F; Walsberger S; D'Este C; Paul C; Dunlop A; Searles A; Kelly P; Fry R; Stirling R; Fowlie C; Skelton E, 2016, 'An organisational change intervention for increasing the delivery of smoking cessation support in addiction treatment centres: Study protocol for a randomized controlled trial', Trials, 17, http://dx.doi.org/10.1186/s13063-016-1401-6

Farrell MP; Truman GJ; Shea R; Hughes DJ; Gallagher DJ, 2016, 'Frequency of variants of uncertain significance in BRCA1 and BRCA2 in an Irish cohort.', JOURNAL OF CLINICAL ONCOLOGY, 34, http://dx.doi.org/10.1200/JCO.2016.34.15_suppl.e13006

Gowing L; Farrell M; Ali R; White JM, 2016, 'Alpha2-adrenergic agonists for the management of opioid withdrawal', Cochrane Database of Systematic Reviews, 2016, http://dx.doi.org/10.1002/14651858.CD002024.pub5

Darke S; Farrell M, 2016, 'Response to commentaries on 'Which medications are suitable for agonist drug maintenance'', Addiction, 111, pp. 781 - 782, http://dx.doi.org/10.1111/add.13359

Darke S; Farrell M, 2016, 'Which medications are suitable for agonist drug maintenance?', Addiction, 111, pp. 767 - 774, http://dx.doi.org/10.1111/add.13158

Back to profile page